Treatment Strategies for Periprosthetic Proximal Femoral Fractures of Type B2/B3 – Comparing Revision Prostheses with Osteosynthesis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039846

Enrollment

150

Registered

2026-04-02

Start date

2026-04-13

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

S72

Interventions

Group 1: Patients with periprosthetic femur fractures who were treated between January 1st 2021 to December 31th 2025 with an osteosynthesis. The study data are collected retrospectively from medical

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: – Periprosthetic femoral fracture (B2 + B3) – osteosynthesis or revision arthroplasty

Exclusion criteria

Exclusion criteria: – patient died during the hospital stay

Design outcomes

Primary

Measure	Time frame
Time to first mobilisation after surgery. The primary endpoint is measured in hours between the end of surgery and the time of mobilisation from the hospital bed. The dates and hours are collected retrospectively from the patient’s medical record.	—

Secondary

Measure	Time frame
• Transfusion rate • Revision rate (surgical) • Complications (pneumonia, urinary tract infection, thrombosis, ulcers) • Length of hospital stay • Time to surgery • Documented mobilization prior to discharge/transfer	—

Countries

Germany

Contacts

Public ContactAlexander Teske-Schauer

BG Klinikum Unfallkrankenhaus Berlin

alexander.teske-schauer@ukb.de+493056813013

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026